There are 83 clinics – down from 153 in 2018/19 – in the Free State with Ideal Clinic status, meaning they have adequate staff, infrastructure, and medicines, among others. For many primary health facilities, this accreditation status is crucial for the National Health Insurance, however, some of these ideal clinics still have various shortcomings. Refilwe Mochoari reports.
Respiratory Syncytial Virus (RSV) is estimated to affect 64 million people and claim around 160 000 lives around the world every year. Infants are most vulnerable and there is no effective treatment or vaccine. Tiyese Jeranji asks what we know about RSV in South Africa.
South Africa’s fifth wave of COVID-19 infections was comparatively small and is already abating. As with the fourth wave, infection was much less likely to result in hospitalisation or death than in the first three waves. In light of these changes in the pandemic, Aisha Abdool Karim asks what the “new normal” should look like when it comes to mask-wearing, ventilation, hand sanitising, and other preventive measures.
The risk of a hospitalised person dying from COVID-19 in the Eastern Cape was almost double the risk of someone dying of the disease in the Western Cape, according to a study published in the South African Journal of Science. Adele Baleta unpacks the study’s rich set of findings on hospitalisation and death in South Africa.
South African bioinformatics expert Professor Tulio de Oliveira was recently honoured with Time Magazine’s 100 most influential people award. Biénne Huisman sat down with him to talk about his part in the discovery of new COVID-19 variants, his chats with the President, and the treasure trove of scientific research excellence in Africa.
In 2019, the Department of Health started providing the antiretroviral drug dolutegravir as part of HIV treatment in the public sector. Three years later, close to 3.2 million people in South Africa are taking dolutegravir every day. Even so, the rollout of dolutegravir hasn’t all been smooth sailing. Elri Voigt investigates how the massive undertaking of switching millions of people to a new drug has gone.
COVID began to hit South Africa badly in May 2020. Now, we are very likely beyond the worst with fewer people dying but COVID remains very infectious and rather deadly, writes Nathan Geffen and Marcus Low.
A rise in teenage pregnancies and gender-based violence coupled with the loss and uncertainty related to COVID-19 are all stressors fuelling the mental health burden the pandemic will leave on children, especially girls. If not adequately addressed, argues Kholofelo Mphahlele, the mental health consequences for a generation of children and young people could far surpass the immediate health and economic impact of the COVID-19 pandemic, leaving harmful long-term social and economic consequences in its wake.
The African Christian Democratic Party and partners are in the High Court today and tomorrow seeking to stop the rollout of COVID-19 vaccines to adolescents. But in a context where the majority of learners attend schools with infrastructure problems and serious overcrowding, vaccines remain a critical tool to keep learners safe and prevent outbreaks of infection at schools, argue Julia Chaskalson and Zeenat Sujee.
The Mpumalanga Department of Health is plagued by many challenges ranging from water shortages affecting some of its health facilities, poor medicine distribution, and a spate of assaults and robberies putting healthcare workers at risk. Nthusang Lefafa spoke to unions, opposition parties, and the department about these ongoing challenges and plans to address them.
Framing the fundamental human right to healthcare as insurance cover opens it up for exploitation. It blocks any possibility of achieving equity in health care. Here Dr Louis Reynolds from the People’s Health Movement of South Africa explains why and how.
While various medicines are produced in South Africa, the active pharmaceutical ingredients going into these medicines are mostly still imported. Catherine Tomlinson reports on a local company that is trying to change that – starting with active pharmaceutical ingredients for tuberculosis and COVID-19 medicines.
